SPCC584.03c Antibody

What is SPCC584.03c protein and why is it studied in fission yeast?

SPCC584.03c (Uniprot: O94589) is a protein found in Schizosaccharomyces pombe (fission yeast), which serves as an important model organism for studying fundamental cellular processes. Fission yeast is particularly valuable for research because it shares many key biological pathways with higher eukaryotes, including humans, while maintaining the experimental advantages of a unicellular organism. Studying SPCC584.03c can provide insights into protein function and cellular processes that may be conserved across species .

The protein is studied primarily through immunological methods that require specific antibodies. Research using this approach helps elucidate protein-protein interactions and functional roles in cellular pathways, which is instrumental for understanding basic biological mechanisms .

What are the technical specifications of the SPCC584.03c antibody?

The SPCC584.03c antibody (Product Code: CSB-PA529702XA01SXV) is a rabbit polyclonal antibody raised against recombinant Schizosaccharomyces pombe (strain 972/ATCC 24843) SPCC584.03c protein. Its specifications include:

The antibody is specifically designed for research use only and should not be utilized for diagnostic or therapeutic procedures .

What are the recommended storage and handling practices for maintaining antibody activity?

To maintain optimal activity of the SPCC584.03c antibody, proper storage and handling are critical:

Upon receipt, store the antibody at -20°C or -80°C immediately. The antibody is supplied in a liquid form with 50% glycerol, which prevents damage from freeze-thaw cycles, but repeated freeze-thaw should still be minimized. When removing aliquots for experiments, briefly spin the vial before opening to recover all material .

For long-term storage stability:

• Prepare small working aliquots (5-20 μL) to avoid repeated freeze-thaw cycles

• Store in polypropylene tubes (preferably low-protein binding) to minimize adsorption to tube walls

• Include carrier proteins (e.g., BSA at 1 mg/mL) in diluted antibody solutions to prevent loss of activity

• Always keep antibodies on ice when in use and return to -20°C or -80°C promptly after use

These practices will help maintain the antibody's specificity and activity over extended periods, ensuring consistent experimental results .

How should I optimize the SPCC584.03c antibody concentration for pull-down experiments?

Optimizing antibody concentration for pull-down experiments requires a systematic titration approach to balance sufficient target capture with minimal non-specific binding:

• Initial titration experiment:

  • Test 3-5 different antibody concentrations (typically ranging from 1-10 μg per 1 mg total protein)

  • For each concentration, follow the standard pull-down protocol as detailed in the literature

  • Analyze both target protein recovery and non-specific binding by Western blot

• Evaluation metrics:

  Concentration	Target Protein Signal	Background/Non-specific Binding	Signal-to-Noise Ratio
  1 μg	+	+	Calculated ratio
  2.5 μg	++	++	Calculated ratio
  5 μg	+++	+++	Calculated ratio
  10 μg	++++	++++	Calculated ratio

• Select optimal concentration based on:

  • Highest signal-to-noise ratio, not necessarily strongest signal

  • Consistency in pull-down efficiency across replicates

  • Economic considerations for antibody usage

Remember that the optimal concentration may vary depending on expression level of the target protein, complexity of the protein sample, and specific experimental conditions. Including both positive and negative controls at each concentration tested is essential for accurate interpretation .

What is the recommended protocol for co-immunoprecipitation using SPCC584.03c antibody?

A detailed co-immunoprecipitation (Co-IP) protocol optimized for SPCC584.03c antibody in fission yeast follows:

Day 1: Cell Culture and Harvesting

• Grow 100 mL of S. pombe cells to early log phase (~1×10^7 cells/mL)

• Harvest cells by centrifugation at 3,000×g for 2 min at 4°C

• Wash cell pellet once with 50 mL ice-cold 1× PBS

• Resuspend briefly in 1 mL ice-cold lysis buffer without protease inhibitors

• Centrifuge at 5,000×g for 30 sec and measure cell wet weight

Day 2: Cell Lysis and Pre-clearing

• Resuspend cell pellet in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, 10% Glycerol) with freshly added protease inhibitors

• Add 0.9 g cold glass beads and disrupt cells (3 × 3 min with 3 min cooling intervals)

• Collect lysate and add additional lysis buffer to final volume of ~1 mL

• Centrifuge at 20,000×g for 10 min at 4°C to remove debris

• Normalize protein concentration using Bradford assay

• Pre-clear lysate with protein A agarose beads for 1 hour at 4°C (optional but recommended)

Immunoprecipitation and Analysis

• Add 2-5 μg SPCC584.03c antibody to 900 μL cleared lysate

• Incubate with rotation for 1-2 hours at 4°C

• Add 20 μL packed Protein A agarose beads and incubate 1-2 hours at 4°C

• Wash beads 4 times with wash buffer (same as lysis buffer)

• Elute bound proteins with 40 μL 1× Laemmli buffer at 95°C for 5 min

• Analyze by SDS-PAGE and Western blotting with appropriate antibodies for interacting proteins

This protocol can be adjusted based on specific experimental requirements and protein expression levels. Always prepare control samples using non-specific IgG or lysate from untagged strains to identify non-specific interactions .

What controls should be included in experiments using SPCC584.03c antibody?

Proper controls are essential for reliable interpretation of results when using SPCC584.03c antibody. The following controls should be systematically included:

For Western Blot Applications:

• Positive control: Lysate from wild-type S. pombe expressing the SPCC584.03c protein

• Negative control: Lysate from an SPCC584.03c deletion strain (if available)

• Antibody specificity control: Pre-incubation of antibody with excess immunizing peptide

• Loading control: Detection of a housekeeping protein (e.g., actin, tubulin) to normalize protein amounts

For Co-Immunoprecipitation Experiments:

• Input control: Sample of the initial lysate (typically 5-10%) to verify presence of target proteins

• Isotype control: IP with non-specific IgG from the same species as the SPCC584.03c antibody

• Beads-only control: Incubation of lysate with Protein A beads without antibody

• Reciprocal IP: If studying interaction with protein X, perform reverse IP using antibody against protein X

For Pulldown Specificity:

• Competitive binding control: Addition of excess recombinant SPCC584.03c protein to compete for antibody binding

• Stringency controls: Parallel pulldowns with increasing salt concentrations (150, 300, 500 mM NaCl) to assess interaction strength

Why might I observe high background or non-specific binding in pull-down experiments?

High background or non-specific binding is a common challenge in antibody pull-down experiments that can obscure genuine interactions. Several factors may contribute to this issue:

Common Causes and Solutions:

Advanced approaches to reduce background:

• Implement a two-step immunoprecipitation protocol for extremely clean results

• Use cross-linking reagents to stabilize antibody-bead complexes

• Include competing proteins (e.g., BSA) in wash buffers

• Consider using more specific monoclonal antibodies if available for confirmation

Systematic optimization of these parameters should significantly reduce background while maintaining specific signal. Document all optimization steps for reproducibility and publication purposes .

How can I address weak or no signal issues when using SPCC584.03c antibody?

Weak or absent signals in experiments using SPCC584.03c antibody can result from multiple factors affecting either the antibody performance or the target protein detection:

Diagnostic Approach to Weak Signal Issues:

• Verify antibody integrity:

  • Check antibody storage conditions (-20°C or -80°C, minimal freeze-thaw cycles)

  • Run a small amount on SDS-PAGE to confirm intact IgG bands

  • Consider testing antibody functionality with dot blot of recombinant protein

• Target protein considerations:

  • Confirm SPCC584.03c expression level in your strain (by RT-PCR if needed)

  • Ensure protein is not degraded during sample preparation (add extra protease inhibitors)

  • Check for post-translational modifications that might mask epitopes

• Experimental optimization strategies:

  Parameter	Standard Condition	Optimization Options
  Antibody concentration	1-5 μg/IP	Increase to 5-10 μg/IP
  Incubation time	1-2 hours	Extend to overnight at 4°C
  Cell lysis	Mechanical disruption	Try different lysis methods (e.g., enzymatic)
  Buffer composition	Standard IP buffer	Modify detergent type/concentration
  Protein extraction	Standard protocol	Use specialized extraction for membrane proteins if applicable
  Detection method	Standard ECL	Try more sensitive detection (e.g., femto ECL)

• Technical verification steps:

  • Include a positive control in every experiment

  • Confirm primary and secondary antibody compatibility

  • For Western blots following IP, consider using HRP-conjugated TrueBlot secondary antibodies to reduce heavy chain interference

If the protein is expressed at very low levels, consider concentrating the sample using TCA precipitation or similar techniques before immunoprecipitation to increase starting material .

What are the critical parameters to optimize in antibody pull-down experiments with fission yeast?

Successful antibody pull-down experiments in fission yeast require optimization of several critical parameters:

Cell Lysis Efficiency:
Fission yeast cells have tough cell walls that can impede efficient protein extraction. The method of mechanical disruption using glass beads is critical - insufficient disruption leads to poor protein yield, while excessive disruption can cause protein denaturation and aggregation. Optimize disruption cycles (typically 3-5 cycles of 3 minutes each) with cooling periods between cycles to prevent overheating .

Buffer Composition Optimization:

Pre-clearing Parameters:
The pre-clearing step significantly impacts specificity. Optimize:

• Duration (30 min to 2 hours)

• Type of beads (protein A, protein G, or combination)

• Amount of beads (15-50 μL packed volume per mL lysate)

Antibody-Bead Binding Strategy:
Compare direct vs. indirect approaches:

• Direct method: Antibody is added directly to lysate, then beads are added

• Indirect method: Antibody is pre-coupled to beads, then added to lysate

The indirect method may provide cleaner results but can reduce capture efficiency. Test both approaches to determine optimal conditions for your specific target .

Washing Stringency Gradient:
Implement a gradient washing approach with increasing stringency:

• First wash: standard buffer

• Second wash: add 50-100 mM additional NaCl

• Third wash: standard buffer

• Final wash: buffer without detergent

This approach removes non-specific proteins while preserving specific interactions. Document each optimization step methodically for reproducibility and publication purposes .

What adaptations are required to use SPCC584.03c antibody for chromatin immunoprecipitation studies?

Adapting SPCC584.03c antibody for Chromatin Immunoprecipitation (ChIP) studies requires significant protocol modifications to maintain chromatin structure while ensuring antibody accessibility:

ChIP-Specific Protocol Modifications:

• Crosslinking optimization:

  • Start with standard 1% formaldehyde for 10 minutes at room temperature

  • Test crosslinking time gradient (5-20 minutes) to balance between:

    • Sufficient crosslinking to capture transient interactions

    • Avoiding over-crosslinking that can mask epitopes

• Chromatin preparation:

  • After cell lysis, sonication conditions must be carefully optimized

  • Target chromatin fragments of 200-500 bp (versus no fragmentation in standard IP)

  • Test sonication by:

    • Amplitude: 20-40%

    • Cycle pattern: 30 seconds ON, 30 seconds OFF

    • Total sonication time: 5-20 minutes

    • Verify fragment size by agarose gel electrophoresis

• Buffer adaptations:

  Standard IP Buffer	ChIP Adaptation	Rationale
  150 mM NaCl	140 mM NaCl	Maintain chromatin structure
  0.5% NP-40	1% Triton X-100, 0.1% SDS	Better solubilize chromatin
  No SDS	Low SDS (0.1%)	Improve chromatin solubility
  No sodium deoxycholate	0.1% sodium deoxycholate	Enhance nuclear lysis
  Standard protease inhibitors	Add PMSF fresh before use	Prevent epitope degradation

• Antibody amount and incubation:

  • Increase antibody amount to 5-10 μg per ChIP reaction

  • Extend incubation time to overnight at 4°C with rotation

  • Pre-block beads with BSA and sheared salmon sperm DNA to reduce background

• Washing stringency:

  • Implement sequential washes with increasingly stringent buffers

  • Include final high-salt and LiCl washes to reduce non-specific binding

• Controls required specifically for ChIP:

  • Input chromatin (pre-immunoprecipitation sample)

  • Non-specific IgG control

  • Positive control (antibody against histone mark)

  • No-antibody control

• Analysis methods:

  • qPCR for targeted analysis of specific genomic regions

  • ChIP-seq for genome-wide binding profile analysis

This adapted protocol maintains the specificity of the SPCC584.03c antibody while accommodating the unique requirements of chromatin immunoprecipitation experiments .

What considerations are important when designing experiments to compare wild-type and mutant strains using SPCC584.03c antibody?

Experimental Design Principles:

• Strain construction and validation:

  • Confirm genetic modification by sequencing

  • Verify growth characteristics and phenotypes

  • Ensure genetic background is identical except for target mutation

  • Create multiple independent mutant clones to control for clonal effects

• Expression level considerations:

  • Quantify SPCC584.03c expression levels in all strains by RT-qPCR and Western blot

  • If expression levels differ significantly, consider normalized loading or creating strains with similar expression levels

  • Document expression differences and account for them in data interpretation

• Systematic comparison framework:

  Parameter	Comparison Approach	Control Measures
  Protein interactions	Parallel IP with equal protein input	Normalize to bait protein recovery
  Interactor binding affinity	Vary washing stringency	Calculate retention ratio across conditions
  Protein localization	Immunofluorescence with antibody	Include specificity controls
  PTM status	Phospho-specific or other PTM detection	Use appropriate PTM controls
  Complex composition	Size exclusion chromatography followed by IP	Compare complex profiles

• Biological replication strategy:

  • Minimum of three biological replicates for each strain

  • Harvest cells at identical growth phase and density

  • Process all samples in parallel to minimize technical variation

  • Consider randomization of sample processing order

• Quantitative analysis approaches:

  • Implement quantitative Western blotting (with standard curves)

  • Use image analysis software with appropriate background subtraction

  • Apply statistical tests appropriate for your experimental design (t-test, ANOVA)

  • Consider more sensitive detection methods for low-abundance interactions

• Additional controls for mutant analysis:

  • Complementation control (reintroduction of wild-type gene)

  • Temperature-sensitive alleles (if available) for conditional phenotypes

  • Epistasis analysis with related pathway components

How can I distinguish between direct and indirect protein interactions in pull-down experiments?

Distinguishing direct from indirect protein interactions is crucial for accurate interpretation of pull-down results. Several complementary approaches can help make this determination when using SPCC584.03c antibody:

Analytical Strategies:

• Stringency gradient analysis:

  • Perform parallel pull-downs with increasing salt concentrations (150, 300, 500, 750 mM NaCl)

  • Direct interactions typically withstand higher salt concentrations

  • Plot retention curves for each interaction partner:

  Salt Concentration	Direct Interaction	Indirect Interaction
  150 mM NaCl	100%	100%
  300 mM NaCl	80-90%	40-60%
  500 mM NaCl	50-70%	10-30%
  750 mM NaCl	20-40%	0-10%

• Sequential immunoprecipitation:

  • First IP: Capture SPCC584.03c and associated complexes

  • Gentle elution (with peptide or low pH)

  • Second IP: Using antibody against suspected direct interactor

  • Analyze which proteins co-purify in second IP

• In vitro binding assays with recombinant proteins:

  • Express and purify SPCC584.03c and candidate interactors

  • Perform pull-down with purified components only

  • Positive result strongly indicates direct interaction

• Cross-linking mass spectrometry approaches:

  • Use protein cross-linkers with defined spacer arm lengths

  • Identify cross-linked peptides by mass spectrometry

  • Calculate distances between proteins based on cross-linker length

  • Direct interactions will show consistent cross-linking patterns

• Structural biology validation:

  • For high-confidence interactions, consider structural approaches:

    • X-ray crystallography of co-complexes

    • NMR analysis of protein-protein interfaces

    • Cryo-EM for larger complexes

• Domain mapping experiments:

  • Create deletion constructs removing specific protein domains

  • Identify minimal regions required for interaction

  • Design point mutations in interface residues to disrupt specific interactions

By combining multiple approaches from this analytical pipeline, researchers can build strong evidence for direct versus indirect protein interactions with SPCC584.03c, creating a hierarchical interaction network with high confidence .

What quantitative methods are most appropriate for analyzing co-immunoprecipitation data using SPCC584.03c antibody?

Densitometry-Based Quantification:

• Western blot band intensity analysis:

  • Capture images using a dynamic range-appropriate system (CCD camera-based)

  • Use software (ImageJ, Image Lab, etc.) for densitometric analysis

  • Ensure analysis is performed in the linear range of detection

  • Express results as ratio of co-IP protein to bait protein

• Normalization approaches:

  • To bait protein recovery (accounts for IP efficiency)

  • To input levels (accounts for expression differences)

  • Relative to control IP (accounts for background binding)

  Recommended calculation: Enrichment factor = (Target/Bait)_sample ÷ (Target/Bait)_control

Mass Spectrometry-Based Quantification:

• Label-free quantification (LFQ):

  • Compare peptide intensities across samples

  • Calculate protein abundance using algorithms like MaxLFQ

  • Advantages: Simple workflow, no labeling required

  • Limitations: Lower precision than labeling methods

• SILAC (Stable Isotope Labeling with Amino acids in Cell culture):

  • Label experimental and control cultures with heavy/light amino acids

  • Mix samples prior to IP to eliminate technical variation

  • Calculate heavy/light ratios for quantitative comparison

  • Ideal for comparing wild-type vs. mutant interactions

• TMT (Tandem Mass Tag) labeling:

  • Allow multiplexing of up to 16 conditions

  • Suitable for time course or multiple treatment comparisons

  • Provides higher throughput than SILAC

Statistical Analysis Framework:

Data Visualization Approaches:

• Volcano plots (fold change vs. statistical significance)

• Heatmaps for multi-protein interaction networks

• Interaction matrices with color-coded strength values

• Principal component analysis for pattern identification

For most rigorous analysis, combining orthogonal quantification methods (e.g., Western blot validation of key MS findings) is recommended. Regardless of method, thorough reporting of quantification parameters and statistical tests is essential for publication-quality results .

How should I interpret contradictory findings between different experimental approaches when studying SPCC584.03c interactions?

Contradictory findings between different experimental approaches studying SPCC584.03c interactions are common and represent an important opportunity for deeper biological insights rather than simply experimental failure. A systematic framework for interpretation and resolution involves:

Contradiction Analysis Framework:

• Methodological comparison:
  Begin by carefully documenting the precise experimental conditions where contradictions occur:

  Parameter	Approach A	Approach B	Potential Impact
  Cell lysis method	Mechanical disruption	Detergent lysis	Different protein complexes extracted
  Buffer composition	Low salt (150mM)	High salt (300mM)	Weak interactions preserved vs. disrupted
  Detection sensitivity	Western blot	Mass spectrometry	Detection limits differ by orders of magnitude
  Expression system	Endogenous	Overexpressed	Non-physiological interactions in overexpression
  Experimental timing	Log phase	Stationary phase	Cell-cycle dependent interactions

• Biological interpretation strategies:

  • Interaction dynamics hypothesis:
    Contradictory results may reflect true biological dynamics rather than experimental artifacts. Consider:

    • Cell-cycle regulation of interactions

    • Post-translational modification-dependent interactions

    • Competitive binding between multiple partners

    • Assembly/disassembly of different complexes under different conditions

  • Interaction strength hierarchy:
    Develop a model of interaction stability where:

    • Core interactions (detected by all methods)

    • Medium-stability interactions (method-dependent detection)

    • Transient interactions (detected only under optimal conditions)

• Resolution approaches:

  • Orthogonal validation:
    Implement a third, independent method to resolve contradictions

  • Targeted mutation analysis:
    Design mutations predicted to specifically disrupt one interaction but not others

  • In vitro reconstitution:
    Test whether purified components recapitulate the interaction behavior

  • Structural biology:
    Determine if both interactions can occur simultaneously or are mutually exclusive

  • Live-cell imaging:
    Visualize interactions in living cells to resolve timing or localization questions

• Integration of contradictory data:
  Rather than dismissing contradictory results, integrate them into a more comprehensive model:

  • Consider context-specific interaction networks

  • Develop "fuzzy" interaction models with probability assignments

  • Present alternative models that incorporate all experimental evidence

  • Design critical experiments specifically to distinguish between models

• Reporting recommendations:
  When publishing work with contradictions:

  • Transparently report all findings, including contradictory results

  • Discuss potential biological and technical explanations

  • Avoid overinterpreting either positive or negative results

This framework transforms apparent contradictions from experimental obstacles into deeper insights about the contextual nature of SPCC584.03c interactions and their biological regulation .

What are the emerging techniques that may enhance research using SPCC584.03c antibody?

Several cutting-edge techniques are emerging that can significantly enhance the research potential of SPCC584.03c antibody beyond traditional applications:

Proximity-Based Labeling Approaches:
By combining SPCC584.03c antibody with newer proximity labeling techniques, researchers can map spatial interaction networks with unprecedented detail:

• BioID or TurboID fusion proteins to identify proteins in proximity to SPCC584.03c

• APEX2 peroxidase-based proximity labeling for temporal interaction dynamics

• Split-BioID systems to identify interactions occurring only under specific conditions

These approaches overcome limitations of traditional co-IP by capturing weak or transient interactions that would be lost during cell lysis and washing steps .

Advanced Microscopy Applications:

• Super-resolution microscopy combined with SPCC584.03c antibody for nanoscale localization

• Single-molecule tracking to follow individual SPCC584.03c molecules in living cells

• Fluorescence correlation spectroscopy (FCS) to measure interaction kinetics in real-time

• 4D imaging (3D + time) to track dynamic changes in SPCC584.03c localization during cell cycle

Integrative Multi-Omics Approaches:
Combining SPCC584.03c antibody-based techniques with other omics approaches can provide systems-level understanding:

• ChIP-seq + RNA-seq to correlate SPCC584.03c genomic binding with transcriptional outcomes

• IP-MS + Metabolomics to identify metabolic enzymes affected by SPCC584.03c interactions

• Proteomics + Structural modeling to predict interaction interfaces

• Network analysis algorithms to place SPCC584.03c in global cellular interaction maps

Microfluidics and Single-Cell Analysis:

• Microfluidic antibody capture devices for analyzing rare cell populations

• Single-cell proteomics to examine cell-to-cell variation in SPCC584.03c interactions

• Droplet-based single-cell Western blotting for quantifying proteins in individual cells

CRISPR-Based Functional Genomics:
Combining CRISPR technology with SPCC584.03c antibody research:

• CRISPR screens to identify genes affecting SPCC584.03c interactions

• CUT&RUN or CUT&Tag as alternatives to traditional ChIP with higher sensitivity

• CRISPR-based tagging of endogenous proteins for validation of interactions